BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 23714256)

  • 21. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
    Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma.
    Miyahara M; Tanuma J; Sugihara K; Semba I
    Cancer; 2007 Sep; 110(6):1287-94. PubMed ID: 17674352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour.
    de la Torre NG; Buley I; Wass JA; Turner HE
    Endocr Relat Cancer; 2006 Sep; 13(3):931-44. PubMed ID: 16954441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intratumoral lymphatics and lymphatic vessel invasion detected by D2-40 are essential for lymph node metastasis in bladder transitional cell carcinoma.
    Ma Y; Hou Y; Liu B; Li X; Yang S; Ma J
    Anat Rec (Hoboken); 2010 Nov; 293(11):1847-54. PubMed ID: 20730866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker.
    Zhao D; Wang SH; Feng Y; Hua CG; Zhao J; Tang XF
    Hum Pathol; 2011 Oct; 42(10):1514-23. PubMed ID: 21531000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pericyte coverage of differentiated vessels inside tumor vasculature is an independent unfavorable prognostic factor for patients with clear cell renal cell carcinoma.
    Cao Y; Zhang ZL; Zhou M; Elson P; Rini B; Aydin H; Feenstra K; Tan MH; Berghuis B; Tabbey R; Resau JH; Zhou FJ; Teh BT; Qian CN
    Cancer; 2013 Jan; 119(2):313-24. PubMed ID: 22811049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix.
    Gombos Z; Xu X; Chu CS; Zhang PJ; Acs G
    Clin Cancer Res; 2005 Dec; 11(23):8364-71. PubMed ID: 16322297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosis.
    Miyata Y; Kanda S; Ohba K; Nomata K; Eguchi J; Hayashida Y; Kanetake H
    J Urol; 2006 Jul; 176(1):348-53. PubMed ID: 16753442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
    Zeng Y; Opeskin K; Goad J; Williams ED
    Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzyme histochemical analysis of lymphatic vessels in colon carcinoma: occurrence of lymphangiogenesis within the tumor.
    Kuroyama S; Kobayashi N; Ohbu M; Ohtani Y; Okayasu I; Kakita A
    Hepatogastroenterology; 2005; 52(64):1057-61. PubMed ID: 16001629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperplasia of pericytes is one of the main characteristics of microvascular architecture in malignant glioma.
    Sun H; Guo D; Su Y; Yu D; Wang Q; Wang T; Zhou Q; Ran X; Zou Z
    PLoS One; 2014; 9(12):e114246. PubMed ID: 25478951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder.
    Fernández MI; Bolenz C; Trojan L; Steidler A; Weiss C; Alken P; Grobholz R; Michel MS
    Eur Urol; 2008 Mar; 53(3):571-8. PubMed ID: 17804149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-associated lymphangiogenesis in the development of conjunctival squamous cell carcinoma.
    Heindl LM; Hofmann-Rummelt C; Adler W; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
    Ophthalmology; 2010 Apr; 117(4):649-58. PubMed ID: 20346821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphangiogenesis in gastric carcinoma correlates with prognosis.
    Gao P; Zhou GY; Zhang QH; Su ZX; Zhang TG; Xiang L; Wang Y; Zhang SL; Mu K
    J Pathol; 2009 Jun; 218(2):192-200. PubMed ID: 19224540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis.
    Bolenz C; Fernández MI; Trojan L; Hoffmann K; Herrmann E; Steidler A; Weiss C; Ströbel P; Alken P; Michel MS
    BJU Int; 2009 Apr; 103(8):1040-6. PubMed ID: 18990139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional difference in intratumoral lymphangiogenesis of oral squamous cell carcinomas evaluated by immunohistochemistry using D2-40 and podoplanin antibody: an analysis in comparison with angiogenesis.
    Ohno F; Nakanishi H; Abe A; Seki Y; Kinoshita A; Hasegawa Y; Tatematsu M; Kurita K
    J Oral Pathol Med; 2007 May; 36(5):281-9. PubMed ID: 17448138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiogenesis with pericyte abnormalities in a transgenic model of prostate carcinoma.
    Ozawa MG; Yao VJ; Chanthery YH; Troncoso P; Uemura A; Varner AS; Kasman IM; Pasqualini R; Arap W; McDonald DM
    Cancer; 2005 Nov; 104(10):2104-15. PubMed ID: 16208706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension?
    Heindl LM; Hofmann TN; Adler W; Knorr HL; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
    Ophthalmology; 2010 Feb; 117(2):334-42. PubMed ID: 19892405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of biochemical recurrence after radical prostatectomy using peritumoral lymphatic vessel density in biopsy specimens in patients with localized prostate cancer.
    Kuroda K; Horiguchi A; Asano T; Tasaki S; Yoshii H; Sato A; Asakuma J; Ito K; Seguchi K; Sumitomo M; Asano T
    Urol Int; 2012; 88(1):18-24. PubMed ID: 22222198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.